secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2026-07-16T10:01:18+00:00
Accession:  0001193125-26-305344
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex alleges stealth proxy campaign by Novel; Novel discloses 39% stake after belated 13D filing
--------------------------------------------------------------------------------

- All five director nominees elected despite 'withhold' campaign targeting Huss and Shuda; plurality standard applied.
- Board alleges Novel and a 'Group of 17' coordinated withhold campaign, violating SEC proxy rules.
- Novel amended Schedule 13D on July 13, 2026, disclosing 6.7M shares (39% of common, 29.9% fully diluted).
- Company investigating whether Novel's purchases included March 27, 2026, 30% drop before conversion price reset proposal.
- Novel offered to change its vote if one targeted director resigned and investigation ended; Board rejected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000119312526305344/0001193125-26-305344-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000119312526305344/d101758d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-305344

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer